Calcium phosphate-PEG-insulin-casein (CAPIC) particles as oral delivery systems for insulin

International Journal of Pharmaceutics

Volumn 277, Issue 1-2, 2004, Pages 91-97

  Morcol T ^a   Nagappan, P ^a   Nerenbaum, L ^a   Mitchell, A ^a   Bell, S J D ^a  

^a BioSante Pharmaceuticals Inc   (United States)

Author keywords

Calcium phosphate particles; Diabetes; Insulin; Oral drug delivery; Oral insulin formulation; Sustained release drug delivery

Indexed keywords

CALCIUM PHOSPHATE; CASEIN; GLUCOSE; MACROGOL 3350; RECOMBINANT HUMAN INSULIN;

ACIDITY; ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD GLUCOSE MONITORING; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DRUG ABSORPTION; DRUG ACTIVITY; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; FEMALE; GASTROINTESTINAL TRACT; GLUCOSE BLOOD LEVEL; INTESTINE ABSORPTION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANIMALS; CALCIUM PHOSPHATES; CASEINS; CATTLE; DIABETES MELLITUS, EXPERIMENTAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; INSULIN; MICE; MICE, INBRED NOD; MICROSCOPY, ELECTRON, SCANNING; PARTICLE SIZE; POLYETHYLENE GLYCOLS;

EID: 2442672527     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2003.07.015     Document Type: Conference Paper

References (16)

1. Abbas, R., Baugham, R.A., Vries, D., Dinh, S., Arbit, E., 2001. Pharmacokinetics of human insulin delivered orally in healthy volunteers, Poster presentation. Diabetes Technology Meeting, San Francisco, 2-3 November.
2. Bell, S.J.D., Morcol, T., He, Q., 2002. Therapeutic calcium phosphate particles and method of manufacture and use. US Patent 6,355,271.
3. Carino G.P., Mathiowitz E. Oral insulin delivery. Adv. Drug Deliv. Rev. 35:1999;249-257
4. Coudhari, K.B., Labhasetwar, V., Dorle, A.K., 1994. Liposomes as carrier for oral administration of insulin: Effect of formulation factors. J. Microencapsul. 11, 319-325.
5. Damage, C., Michel, C., Aprahamian, M., Couvreur, P., 1988. New approach for oral administration of insulin with polyalkyocyanoacrylate nanocapsules as drug carrier. Diabetes 37, 246-251.
6. He Q., Mitchell A.R., Johnson S.L., Wagner-Bartak C., Morcol T., Bell S.J.D. Calcium phospahe nanoparticle adjuvant. Clin. Diagn. Lab. Immunol. 7:2000;899-903
7. Hosney, E.A., Ghilzai, N.M.K., Al-Najar, A., Elmazar, M.M.A., 1998. Hypoglycemic effect of oral insulin in diabetic rabbits using pH-dependent coated capsules containing sodium salicylate without and with sodium cholate. Drug Dev. Ind. Pharm. 24, 307-311.
8. Loehry, C.A., Axon, A.T.R., Hilton, P.J., Hider, R.C., Creamer, B., 1970. Permeability of the small intestine to substances at different molecular weight. Gut 11, 466-470.
9. Michel, C., Aprahamian, M., Defontaine, L., Couvreur, P., Damge, C., 1991. The effect of site of administration in the gastrointestinal tract on the absorption of insulin from nanocapsules in diabetic rats. J. Pharm. Pharmacol. 43, 1-5.
10. Morcol T., He Q., Bell S.J.D. Model process for removal of caseins from milk of transgenic animals. Biotechnol. Prog. 17:2001c;577-582
11. Modi, P., 2001. The evolving role of oral insulin in treatment of diabetes, Poster presentation. Diabetes Technology Meeting, San Francisco, 2-3 November.
12. Morcol, T., Bell, S.J.D., 2001b. Method for processing milk. US Patent 6,183,803.
13. Morcol, T., Nagappan, P., He, Q., Bell, S.J.D., 2001a. Calcium phosphate particles as pulmonary and injectable insulin delivery system in diabetic mice, Poster presentation. Diabetes Technology Meeting, San Francisco, 2-3 November.
14. Price, C.H., 2001. Oral delivery of modified insulin. Diabetes Technology Meeting San Francisco, 2-3 November.
15. Skyler J.S., Cefalu W.T., Kourides I.A., Landschultz W.H., Balagtas C.C., Cheng S.L., Gelfand R.A. Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomized proof-of-concept study. Lancet. 357:2001;331-335
16. Trehan A., Ali A. Recent approaches in insulin delivery. Drug Dev. Ind. Pharm. 26:1998;589-597